PHASE II STUDY OF BEVACIZUMAB AND ERLOTINIB IN PATIENTS WITH NON-SQUAMOUS NON-SMALL LUNG CANCER THAT IS REFRACTORY OR RELAPSED AFTER 1-2 PREVIOUS TREATMENT (BEST STUDY)
JOURNAL OF THORACIC ONCOLOGY（2013）
Key words
erlotinib,Bevacizumab,phase II,2-3 treatment
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined